Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Shares withheld for taxes SENIOR VICE PRESIDENT AND CFO gave up 1,461 shares (to pay taxes)
  2. 4 Shares withheld for taxes SVP - NEW BUS DEV & SPEC SALES gave up 5,566 shares (to pay taxes)
  3. 4 Grant or award SVP OPS & PROD DEV acquired 32,041 shares (grant or award)
  4. 4 Grant or award SENIOR VICE PRESIDENT AND CFO acquired 54,470 shares (grant or award)
  5. 4 Grant or award PRESIDENT & CEO acquired 136,495 shares (grant or award)
  6. 4 Grant or award Director acquired 9,292 shares (grant or award)
  7. 4 Grant or award Director acquired 9,292 shares (grant or award)
  8. 4 Grant or award Director acquired 9,292 shares (grant or award)
  9. 4 Grant or award Director acquired 9,292 shares (grant or award)
  10. 4 Grant or award Director acquired 9,292 shares (grant or award)
  11. 4 Grant or award Director acquired 9,292 shares (grant or award)
  12. 4 Open-market buy Director bought 4,000 shares at $32.89 ($131,555)
  13. 4 Grant or award CHIEF COMMERCIAL OFFICER acquired 16,134 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award SVP, GENERICS acquired 12,907 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Director bought 5,000 shares at $25.96 ($129,800)
  18. 4 Grant or award PRESIDENT & CEO acquired 28,508 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy CHAIRMAN, INTERIM PRES. & CEO bought 10,000 shares at an average $30.78 ($307,790)

Page 18 of 42 · 835 filings